Fulvio L F Giovenzana

7PUBLICATIONS
37CO-AUTHORS
Molecular targetsHaematological tumoursExercise physiologyEthical use of new technologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 22, 2026
Targeting trafficking defects in long QT syndrome type 2: a phase 2 clinical study with patient-specific cellular validation.

|May 13, 2026
MTMR4 variants have opposite gene-specific impact on life-threatening arrhythmic risk in type 1 and 2 long QT syndrome.

|Jul 15, 2025
TP-fusion at peak exercise: a novel marker for the recognition of unsuspected long QT syndrome patients.

Carlo Boeri, Patrizio Sarto, Paolo Cerea

|Feb 21, 2025
Managing long QT syndrome patients, cooking, and common sense.

Peter J Schwartz, Federica Dagradi, Fulvio L F Giovenzana

|Jun 28, 2024
Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and Patients.

Lia Crotti, Raquel Neves, Federica Dagradi

|May 16, 2024
Long QT syndrome: importance of reassessing arrhythmic risk after treatment initiation.

Veronica Dusi, Federica Dagradi, Carla Spazzolini

Pageof 2

Frequent Collaborators

7 joint publications

Federica Dagradi

7 joint publications

Peter J Schwartz

5 joint publications

Lia Crotti

5 joint publications

Paolo Cerea